Large chalazia affecting multiple eyelids associated with bortezomib

被引：0
|
作者：
Grob, Seanna [1 ,2 ]
Jakobiec, Frederick [2 ,3 ]
Rashid, Alia [2 ,3 ]
Yoon, Michael K. [1 ,2 ]
机构：
[1] Massachusetts Eye & Ear Infirm, Oculoplast, Boston, MA 02114 USA
[2] Harvard Med Sch, Ophthalmol, Boston, MA USA
[3] Massachusetts Eye & Ear Infirm, David G Cogan Ophthalm Pathol Lab, Boston, MA 02114 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
526; eyelid; 503 drug toxicity/drug effects; 624; oncology;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3114
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenstroms Macroglobulinemia
    Laubach, Jacob P.
    Mitsiades, Constantine S.
    Roccaro, Aldo M.
    Ghobrial, Irene M.
    Anderson, Kenneth C.
    Richardson, Paul G.
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 694 - 702
  • [42] Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
    Salmenniemi, Urpu
    Remes, Kari
    HEMATOLOGY REPORTS, 2012, 4 (02) : 37 - 38
  • [43] Erectile Dysfunction Associated With Bortezomib Treatment in a Patient With Multiple Myeloma and Amyloidosis
    Pri-Chen, Hadass
    Chari, Ajai
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (03): : 331 - 332
  • [44] Multiple myeloma associated with porphyria cutanea tarda: A possible role of bortezomib?
    Cabanillas, Miguel
    Peteiro, Carmen
    Toribio, Jaime
    DERMATOLOGY, 2006, 213 (03) : 246 - 247
  • [45] Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B
    Goldberg, R.
    Smith, E.
    Bell, S.
    Thompson, A.
    Desmond, P. V.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (07) : 835 - 836
  • [46] Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma
    Van Keer, Jan
    Delforge, Michel
    Dierickx, Daan
    Peerlinck, Kathelijne
    Lerut, Evelyne
    Sprangers, Ben
    CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [47] Clinical and Immunohistochemical Features Associated with a Response to Bortezomib in Patients with Multiple Myeloma
    Dawson, Mark A.
    Opat, Stephen S.
    Taouk, Yamna
    Donovan, Mark
    Zammit, Michele
    Monaghan, Katherine
    Horvath, Noemi
    Roberts, Andrew W.
    Prince, H. Miles
    Hertzberg, Mark
    McLean, Catriona A.
    Spencer, Andrew
    CLINICAL CANCER RESEARCH, 2009, 15 (02) : 714 - 722
  • [48] A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment
    Mauermann, Michelle L.
    Blumenreich, Martin S.
    Dispenzieri, Angela
    Staff, Nathan P.
    MUSCLE & NERVE, 2012, 46 (06) : 970 - 977
  • [49] Management of toxicities associated with bortezomib - From the Multiple Myeloma Research Foundation
    Lonial, Sagar
    ONCOLOGY-NEW YORK, 2006, 20 (12): : 1592 - +
  • [50] Bortezomib in multiple myeloma
    Meisler, AI
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13): : 1287 - 1287
12345